Advertisement

Pharmacy World and Science

, Volume 24, Issue 6, pp 217–223 | Cite as

Data collection methods for analyzing the quality of the dispensing in pharmacies

  • Francisco CaamañoEmail author
  • Alberto Ruano
  • Adolfo Figueiras
  • J.J. Gestal‐Otero
Article

Abstract

Objective: To review and discuss the advantages and limitations of the different data collection methods for analyzing the dispensing quality in community pharmacies. Methods: A bibliographic search was carried out in MEDLINE (1980‐2000). Articles with Medical Subject Heading (Mesh) “pharmacies”written in English and Spanish that evaluated the quality of dispensing (structure, process or outcome) were selected.Results: Various data collection methods were observed. To analyze the quality of the structure, questionnaires and pharmacist interviews were used. To analyze the quality of the process, self‐completed records, external observers and simulated clients were used. For analyzing the quality of the outcome, questionnaires, client interviews, and biologic samples were collected. Conclusions: The analysis of quality of structure can be useful as a first approach, however, this method may lack sensitivity. On the other hand, the analysis of outcome may be excessively complex and difficult to use, except for experimental or observational studies with large resources. Therefore, an analysis of the quality of the process is the best option. Methods utilizing external observers and simulated clients may best conjugate both internal and external validity.

Community pharmacy Data collection Dispensing quality Methodology Pharmacist Pharmacy practice research Prescriptions 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rawlin MD. Extending the role of the community pharmacist. BMJ 1991;302:427-8.Google Scholar
  2. 2.
    Gallager F, Zander L. General practitioner and the pharmacist. BMJ 1983;287:397-8.Google Scholar
  3. 3.
    Bond CM, Bradley C. The interface between the community pharmacist and patients. BMJ 1996;312:758-60.Google Scholar
  4. 4.
    Joint Commission of Pharmacy Practitioners. Provisional draft mission statement for pharmacy practice. Am J Hosp Pharm 1991;47:533-43.Google Scholar
  5. 5.
    Hepler CD. Can a community pharmacist add value to prescriptions? Am Pharm 1993;33:46-7.Google Scholar
  6. 6.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.Google Scholar
  7. 7.
    Rupp MT. Value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother 1992;26: 1580-4.Google Scholar
  8. 8.
    Álvarez F, Zardain E, Eyaralar T, Dago AM, Arcos P. Detección del error de prescripción en la dispensación farmacéutica incidencia y tipología. Aten Primaria 1993;11:70-4.Google Scholar
  9. 9.
    Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care 1992;30:926-40.Google Scholar
  10. 10.
    Rupp MT. Evaluation of prescribing errors and pharmacist interventions in community practice: an estimate of “value added”. Am Pharm 1988;28:22-6.Google Scholar
  11. 11.
    Rupp MT, Schondelmeyer SW, Wilson GT, Krause JE. Documenting prescribing errors and pharmacist interventions in community phramacy practice. Am Pharm 1988;9:30-6.Google Scholar
  12. 12.
    Aguirre MC, Ortiz JA, García de Vicuña B, Gorostiza I, Ruiz J. Evaluación de la información al paciente en las oficinas de farmacia. Aten Primaria 1993;11:33-7.Google Scholar
  13. 13.
    Willison DJ, Muzzin LJ. Workload, data gathering, and quality of community pharmacists' advice. Med Care 1995;33: 29-40.Google Scholar
  14. 14.
    Smith FJ. Factors important to clients when seeking advice of pharmacists. Pharm J 1990;244:692-3.Google Scholar
  15. 15.
    Caamaño F, Figueiras A, Lado E, Gestal-Otero JJ. La automedicación: Concepto y perfil de sus “usuarios”. Gac Sanit 2000;14:294-9.Google Scholar
  16. 16.
    Servicio Catalán de Salud. Libro blanco para la integración de las actividades preventivas en la oficina de farmacia. Servicio catalán de salud. Barcelona, 1998.Google Scholar
  17. 17.
    Ibrahim OM, Catania PN, Mergener MA, Supernaw RB. Outcome of cholesterol screening in a community-pharmacy. Ann Pharmacother 1990;24:817-21.Google Scholar
  18. 18.
    Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyper-lipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997;31:713-9.Google Scholar
  19. 19.
    Dickson WM, Rodowskas CA. Verbal communications of community pharmacists. Med Care 1975;13:486-98.Google Scholar
  20. 20.
    Airaksinen M, Ahonen R, Enlund Hannes. The “Questions to ask about your medicines” campaign. An evaluation of pharmacists and the public's response. Med Care 1998;36:422-7.Google Scholar
  21. 21.
    Machuca M. Sobre la necesidad de la investigación en farmacia comunitaria. Pharm Care Esp 2000;2:307-9.Google Scholar
  22. 22.
    Singhal P, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999;33:1336-53.Google Scholar
  23. 23.
    Donabedian A. Explorations in quality assessment and monitoring. Vol I: The definition of quality and approaches to its assessment. Ann Arbor: Health Administration Press, 1980.Google Scholar
  24. 24.
    Donabedian A. Explorations in quality assessment and monitoring. Vol II: The criteria and standards of quality. Ann Arbor: Health Administration Press, 1982.Google Scholar
  25. 25.
    Briggs A, Scott E, Steele K. Analgesics: a comparison of therapeutic knowledge and inter-professional liaison between general practitioners and community pharmacists. Br J Gen Pract 1997;47:378-9.Google Scholar
  26. 26.
    Cancrinus-Matthijsse AM, Lindenberg SM, Bakker A, Groenewegen PP. The quality of the professional practice of community pharmacists: what can still be improved in Europe? Pharm World Sci 1996;18:217-28.Google Scholar
  27. 27.
    Kafle KK, Madden JM, Shrestha AD, Karkke SB, Das PL, Pradhan YM, Quick JD. Can licensed drug sellers contribute to safe motherhood? A survey of the treatment of pregnancy-related anaemia in nepal. Soc Sci Med 1996;42:1577-87.Google Scholar
  28. 28.
    Goodburn E, Mattosinho S, Mongi P, Waterston T. Management of childhood diarrrhoe by pharmacists and parents: is Britain lagging behind the Third World? BMJ 1991;302:440-3.Google Scholar
  29. 29.
    Spencer JA, Edwards C. Pharmacy beyond the dispensary: general practitioner' views. BMJ 1992;304:1670-2.Google Scholar
  30. 30.
    Raisch D. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings. Ann Pharmacother 1993;27:1173-9.Google Scholar
  31. 31.
    Pendergast JF, Kimberlin CL, Berardo DH, McKenzie LC. Role orientation and community pharmacists' participation in a project to improve patient care. Soc Sci Med 1995;40:557-65.Google Scholar
  32. 32.
    Álvarez de Toledo F, Zardain E, Eyaralar T, Dago AM, Arcos P. Detección del error de prescrpción en la dispensación farmacéutica: incidencia y patología. Aten Primaria 1993;11:70-4.Google Scholar
  33. 33.
    Bernárdez M, Puche E, Martínez B, Gracía-Morillas M, Luna JD. Estudio framacoepidemiológico a largo plazo sobre dispensación de fármacos por la oficina de farmacia en AP rural. Influencia de edad y sexo. Aten Primaria 1997;19;25-31.Google Scholar
  34. 34.
    Chamba G, Bauguil G, Gallezot J. The role of the French community pharmacist in drug dispensing. Pharm World Sci 1999;21:142-3.Google Scholar
  35. 35.
    Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999;47:695-700.Google Scholar
  36. 36.
    Figueiras A, Sastre I, Lado E, Tato F, Caamaño F, Gestal-Otero JJ. One to One vs. Group Education Improving on Primary Care: A Pragmatic Randomized Controlled Trial. Med Care 2001;39:158-67.Google Scholar
  37. 37.
    Last JM. Diccionario de epidemiología. Barcelona: Salvat Editores, 1989.Google Scholar
  38. 38.
    Ward PR, Bissell P, Noyce PR. Criteria for assessing the appropriateness of patient counseling in community pharmacies. Ann Pharmacother 2000;34:170-5.Google Scholar
  39. 39.
    Caamaño F, Lado E, Gestal-Otero JJ. ¿Es legítimo el uso de placebo en atención primaria? Aten Primaria 2000;26:700-2.Google Scholar
  40. 40.
    Wertheimer AI, Balduzzi M, Minghetti P. Reactions of community pharmacists to questions by patients with a stigmatized disease. J Clin Pharm Ther 1991;16:435-42.Google Scholar
  41. 41.
    Zamora AD, Aguilar AM, Valdivia D. Actitudes de los expendedores de farmacias bolivianas frente a un caso de diarrea. Bol Oficina Sanit Panam 1995;118:424-8.Google Scholar
  42. 42.
    Evans RL, Kirk RF, Walker PW, Rosenbluth SA, McDonald J. Medication maintance of mentally ill patients by a pharmacist in a community setting. Am J Hosp Pharm 1976;33: 335-8.Google Scholar
  43. 43.
    Bluml BM, McKenney JM, Cziraky MJ, Elswick RK. Interim Report from project ImPACT: Hyperlipidemia. Collaborative practice model shows promise for improving patient care. J Am Pharm Assoc 1998; 38:529-34.Google Scholar
  44. 44.
    Ibrahim OM, Catania PN, Mergener MA, Supernaw RB. Outcome of cholesterol screening in a community pharmacy. Ann Pharmacother 1990;24:817-21.Google Scholar
  45. 45.
    Gotsch AR, Ligouri S. Knowledge, attitude, and compliance dimensions of antibiotic therapy with PPIs. Med Care 1982;20:581-93.Google Scholar
  46. 46.
    Einarson TR, Bootman JL, McGhan WF, Larson LN, Gardner ME, Donohue M. Establishment and evaluation of aserum cholesterol monitoring service in a community pharmacy. Drug Intell Clin Pharm 1988;22:45-8.Google Scholar
  47. 47.
    Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1997;31:713-9.Google Scholar
  48. 48.
    Mackowiak JI, Gagnon JP. Expectations for ambulatory services in traditional and office-practice pharmacies. Am J Hosp Pharm 1984;41:1140-6.Google Scholar
  49. 49.
    Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc 1996; 36:443-51.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Francisco Caamaño
    • 1
    Email author
  • Alberto Ruano
    • 1
  • Adolfo Figueiras
    • 1
  • J.J. Gestal‐Otero
    • 1
    • 2
  1. 1.Department of Preventive Medicine and Public HealthUniversity of Santiago de CompostelaSpain
  2. 2.Preventive Medicine ServiceUniversity Hospital of Santiago de CompostelaSpain

Personalised recommendations